MEMurat Erdem

Murat Erdem

*This is an algorithmically generated author record based on publicly available information.

Murat Erdem has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Impact of Positive and Negative Affect on QT Dispersion in Healthy Young Adult Men

    by Barbaros Ozdemir, Murat Erdem, Abdullah Bolu, Taner Oznur, Huseyin Gunay, Hakan Balibey, Sarper Ercan, Omer Uz

    Objective: In this study, we aimed to determine whether QT dispersion known to be associated with development of coronary artery disease is related with positive (PA) and negative affect (NA) in healthy young adult men. Method: Two hundred and forty-four healthy males aged between 21–30 years were included in this study. Standard electrocardiographic (12 derivation and 50 mm/sec) and echocardiographic evaluations were performed. The duration of QT dispersion was measured digitally. Patients with sinus bradycardia, sinus tachycardia, bundle branch block, preexcitation and electrolyte imbalances were excluded. PA and NA scores of the subjects were determined by the Positive and Negative Affect Scale and clustered into “high” and “low” affect subtypes. Results: QT dispersion was significantly increased in subjects with high NA compared with those with low NA. There was no difference between the subjects having high PA and low PA. QT dispersion correlated positively with NA but not with PA. Conclusion: The results of this study have shown that there may be a relation between QT dispersion and NA in healthy young adult men.

    • 1 January 2015
      • Vol. 52  (3) , 60-4

    Psychiatric Symptoms and Quality of Life in Military Personnel Deployed Abroad.

    by Taner Oznur, Suleyman Akarsu, Murat Erdem, Murat Durusu, Mehmet Toygar, Yavuz Poyrazoglu, Umit Kaldirim, Mehmet Eryilmaz, Kamil Nahit Ozmenler

    Military personnel deployed abroad could be exposed to more risk factors that adversely affect quality of life. In this study, we examined psychiatric symptoms and quality of life in Turkish Armed Forces deployed to Afghanistan. A total of 289 Turkish military personnel working in Afghanistan enrolled in this study. They completed two surveys containing questions about socio-demographic characteristics. Data were collected and analyzed from 258 of the participants. The general symptom scores (GSI) were above 1 in 20.8 Percent (n=54) of the participants. The lowest SF-36 scores by the sub-groups were mental health (59.14 ± 18.56) and vitality (59.25 ± 21.17). The highest score was in the physical function subscale (84.42 ± 19.53). All Quality of Life Questionnaire Short Form (SF-36)subscale scores were lower in the GSI above 1 group than the GSI below 1 group. In the GSI above 1 group: education level and depression affected SF-36 physical functioning; paranoid ideation and somatization affected SF-36 role limitations due to physical health; age and somatization affected SF-36 pain; age affected SF-36 general health; phobic anxiety affected SF-36 vitality; age, tenure of occupation, tenure abroad; and phobic anxiety affected SF-36 mental health. The negative effects of psychiatric symptoms on the quality of life were similar to those in the general population and in specific disease groups. These results should be considered when evaluating the mental health of military personnel deployed abroad.


  • Open Access

    Mitochondrial complex I and III gene mRNA levels in schizophrenia, and their relationship with clinical features

    by Süleyman Akarsu, Deniz Torun, Abdullah Bolu, Murat Erdem, Salih Kozan, Mehmet Ak, Hatice Akar, Özcan Uzun

    Journal of Molecular Psychiatry is closed and is no longer accepting submissions. You may wish to submit to another BioMed Central journal. Please visit the BioMed Central website for a complete list of our journals. BioMed Central will continue to host an archive of all articles previously published in the journal, and all articles published in Journal of Molecular Psychiatry will remain fully searchable via the BioMed Central website.


  • Open Access

    Polikistik over sendromu olan hastalarda depresyon, anksiyete ve öfke

    by Adem Balıkcı, Murat Erdem, Uğur Keskin, Selma Bozkurt Zincir, Murat Gülsün, Fatih Özçelik, Emin Özgür Akgül, Süleyman Akarsu, Muzaffer Öztosun, Ali Ergün

    • 1 January 2013
      • Vol. 50  (1) , 40-6

    Changes in heart rate variability before and after ECT in the treatment of resistant major depressive disorder.

    by Ali Bozkurt, Cem Barcin, Mehmet Isintas, Mehmet Ak, Murat Erdem, K Nahit Ozmenler

    In this study, we aimed to evaluate the effects of electroconvulsive therapy (ECT) on cardiac autonomic functions (CAF) in patients with major depressive disorder (MDD) using heart rate variability (HRV) analysis. Fourteen men joined the study. Nine ECTs were administered. Holter monitoring was performed before treatment and at the end of the first, third and sixth weeks of the treatment. The Hamilton Depression Rating Scale (HAM-D) was used to assess symptom severity. Seven patients responded to ECT. There was a change of 2-hour resting HF, pNN50 and RMSSD scores between week 0 and week 6. This change was not significant after week 1 and week 3. HRV values did not differ when we grouped the patients as responders and non-responders to ECT except the 2-hour resting HF value of responders between week 0 and week 6 and the 24-hour HF value of non-responders between week 1 and week 6. All observed changes showed a decrease in parameters. Overall, the LF/HF ratio did not change significantly in either analysis. HRV values did not correlate with HAM-D scores and no relation was found between treatment response and HRV analysis. After Benferroni-adjustment none of the changes were found statistically significant. The limitations of the study are the small sample size and the absence of healthy controls. A consistent change in HRV was not observed in response to ECT in patients with MDD. Accepting the HRV as a promising surrogate marker of autonomic activity, ECT does not cause a significant change in nine male treatment resistant MDD patients cardiac autonomic functions.


  • Open Access

    Transcranial Magnetic Stimulation And Use For Diagnostic Purposes In Psychiatry

    by Abdullah Bolu, Murat Erdem, Taner Oznur

    Motor evoked potentials from peripheral nerves, spinal cord or muscle can be recorded by stimulation of the motor cortex and motor pathways in the central nervous system with transcranial magnetic stimulation which is a neurophysiological analysis method. This method allows investigation the mechanism of diseases which cause changes in the excitability of cortical motor areas. Similarly, it was used in determining the effects of psychotropic drugs on cortical activity and electrophysiological measurement of aggressive behavior Transcranial magnetic stimulation studies in the field of psychiatry are focused on etiopathogenesis of pathologies such as schizophrenia, obsessive-compulsive disorder, attention deficit hyperactivity disorder and substance abuse

  • Open Access

    Neurobiology of Placebo Effect

    by Murat Erdem, Suleyman Akarsu, Murat Gulsun

    Placebo is defined as a substance or method that has no specific effect on the condition being treated. Placebo leads to the state of contentment and shows its effects just like a drug by the pathways in the body. Various changes formed by plasebo on the brain activation, neurotransmitters and hormones have been observed with the development of neuroimaging methods. The effects of dopamine, serotonin, and opioid systems in the formation of the placebo response; the relationship between placebo effect, reward cycle and expectation process and the role of the some specific regions in the brain where pharmacological agents acting on during the placebo response have been shown in several studies. There are similarities between hypnosis and the placebo effects and expectation of improvement is closely related to the suggesting phenomenon in the hypnosis as well as placebo responses. The formation of similar changes in the brain after administration of placebo and hypnosis associated with the expectation models and suggestions attracts attention. Neurochemical pathways in the brain constitute functional impact with many of the common mechanisms. Therefore, all of these mechanisms in the placebo response can take part in relation to each other. Although it is known that many factors may influence, understanding of the effects of placebo and viewing the changes in the brain formed by placebo have an important place for enlightening roles of psychological factors in the onset of diseases and treatment